MCID: ADR057
MIFTS: 33

Adrenogenital Syndrome

Categories: Endocrine diseases, Rare diseases

Aliases & Classifications for Adrenogenital Syndrome

MalaCards integrated aliases for Adrenogenital Syndrome:

Name: Adrenogenital Syndrome 59 55

Classifications:

Orphanet: 59  
Rare endocrine diseases


External Ids:

ICD10 33 E25 E25.9
MESH via Orphanet 45 D047808
UMLS via Orphanet 73 C0302280 C0701163
Orphanet 59 ORPHA181412

Summaries for Adrenogenital Syndrome

MalaCards based summary : Adrenogenital Syndrome is related to adrenal insufficiency, congenital, with 46,xy sex reversal, partial or complete and adrenal cortical adenoma. An important gene associated with Adrenogenital Syndrome is CYP21A2 (Cytochrome P450 Family 21 Subfamily A Member 2). The drugs Dexamethasone and Prednisone have been mentioned in the context of this disorder. Affiliated tissues include adrenal gland, cortex and adrenal cortex.

Wikipedia : 75 Congenital adrenal hyperplasia are any of several autosomal recessive diseases resulting from mutations... more...

Related Diseases for Adrenogenital Syndrome

Diseases related to Adrenogenital Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 94)
# Related Disease Score Top Affiliating Genes
1 adrenal insufficiency, congenital, with 46,xy sex reversal, partial or complete 31.0 SYP INHA CYP21A2
2 adrenal cortical adenoma 30.3 SYP CYP21A2
3 lipoid congenital adrenal hyperplasia 30.3 HSD3BP4 CYP21A2 CYP21A1P
4 3-beta-hydroxysteroid dehydrogenase deficiency 30.2 HSD3BP4 CYP21A2
5 adrenal carcinoma 29.8 SYP CYP21A2
6 adrenocortical carcinoma, hereditary 28.3 SYP INHA HSD3BP4 CYP21A2
7 achard thiers syndrome 11.3
8 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 10.7
9 pseudohermaphroditism 10.6
10 adenoma 10.4
11 precocious puberty 10.4
12 premature ovarian failure 7 10.2
13 adrenal cortical carcinoma 10.2
14 hermaphroditism 10.2
15 hypoglycemia 10.2
16 hyperandrogenism 10.2
17 amenorrhea 10.2
18 leydig cell tumor 10.2
19 adrenal cortical adenocarcinoma 10.2
20 infertility 10.2
21 systemic lupus erythematosus 10.1
22 hydrops, lactic acidosis, and sideroblastic anemia 10.1
23 conn's syndrome 10.1
24 myoma 10.1
25 seminoma 10.1
26 adrenal adenoma 10.1
27 lupus erythematosus 10.1
28 diabetes mellitus 10.1
29 malakoplakia 10.1
30 vaginal atresia 10.1
31 acanthosis nigricans 9.9
32 neurofibromatosis, type ii 9.9
33 cornelia de lange syndrome 1 9.9
34 fibrosis of extraocular muscles, congenital, 1 9.9
35 hyperlipoproteinemia, type iv 9.9
36 pheochromocytoma 9.9
37 renal hypodysplasia/aplasia 1 9.9
38 adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency 9.9
39 cryptorchidism, unilateral or bilateral 9.9
40 cystic fibrosis 9.9
41 hemihyperplasia, isolated 9.9
42 intracranial hypertension, idiopathic 9.9
43 phenylketonuria 9.9
44 wilms tumor 5 9.9
45 hyperprolactinemia 9.9
46 autosomal recessive disease 9.9
47 adrenal gland pheochromocytoma 9.9
48 extra-adrenal pheochromocytoma 9.9
49 salmonellosis 9.9
50 hypospadias 9.9

Graphical network of the top 20 diseases related to Adrenogenital Syndrome:



Diseases related to Adrenogenital Syndrome

Symptoms & Phenotypes for Adrenogenital Syndrome

Drugs & Therapeutics for Adrenogenital Syndrome

Drugs for Adrenogenital Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 92)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
2
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
3
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
4
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
5
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
6
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
7
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
8
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
9
Cortisone Experimental Phase 4 53-06-5 222786
10 glucocorticoids Phase 4
11 Gastrointestinal Agents Phase 4
12 Antiemetics Phase 4
13 Prednisolone acetate Phase 4
14 Methylprednisolone Acetate Phase 4
15 BB 1101 Phase 4
16 Anti-Inflammatory Agents Phase 3
17 Hydrocortisone-17-butyrate Phase 3
18 Neuroprotective Agents Phase 3
19 HIV Protease Inhibitors Phase 3
20
protease inhibitors Phase 3
21 Protective Agents Phase 3
22
Hydrocortisone Approved, Vet_approved Phase 1, Phase 2 50-23-7 5754
23
Hydrocortisone acetate Approved, Vet_approved Phase 1, Phase 2 50-03-3
24
Nifedipine Approved Phase 1, Phase 2 21829-25-4 4485
25
Zinc Approved, Investigational Phase 2 7440-66-6 32051
26
Testolactone Approved, Investigational Phase 2 968-93-4 13769
27
Flutamide Approved, Investigational Phase 2 13311-84-7 3397
28
Estradiol Approved, Investigational, Vet_approved Phase 2 50-28-2 5757
29
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
30
Polyestradiol phosphate Approved Phase 2 28014-46-2
31
Testosterone Approved, Experimental, Investigational Phase 2 481-30-1, 58-22-0 6013 10204
32
Fludrocortisone Approved, Investigational Phase 2 127-31-1 31378
33
Calcium Approved, Nutraceutical Phase 1, Phase 2 7440-70-2 271
34 Mineralocorticoids Phase 2
35 Hydrocortisone 17-butyrate 21-propionate Phase 1, Phase 2
36 Hydrocortisone hemisuccinate Phase 1, Phase 2
37 Tocolytic Agents Phase 1, Phase 2
38 Vasodilator Agents Phase 1, Phase 2
39 calcium channel blockers Phase 1, Phase 2
40 Calcium, Dietary Phase 1, Phase 2
41 Pharmaceutical Solutions Phase 2
42 insulin Phase 2
43 Insulin, Globin Zinc Phase 2
44 Hypoglycemic Agents Phase 2
45 Antineoplastic Agents, Hormonal Phase 2
46 Nonsteroidal Anti-Androgens Phase 2
47 Estrogens Phase 2
48 Androgen Antagonists Phase 2
49 Estrogen Receptor Antagonists Phase 2
50 Aromatase Inhibitors Phase 2

Interventional clinical trials:

(show top 50) (show all 51)
# Name Status NCT ID Phase Drugs
1 Congenital Adrenal Hyperplasia: Innovative Once Daily Dual Release Hydrocortisone Treatment Recruiting NCT03760835 Phase 4 Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone);Dual release hydrocortisone (plenadren)
2 Comparative Study of the Use of Glucocorticoids in the Treatment of Congenital Adrenal Hyperplasia in Its Classical Form Unknown status NCT02552251 Phase 2, Phase 3
3 A Phase III Study of Efficacy, Safety and Tolerability of Chronocort® Compared With Standard Glucocorticoid Replacement Therapy in the Treatment of Congenital Adrenal Hyperplasia Completed NCT02716818 Phase 3 Chronocort®;standard glucocorticoid therapy
4 A Phase III Extension Study of Efficacy, Safety and Tolerability of Chronocort® in the Treatment of Congenital Adrenal Hyperplasia Active, not recruiting NCT03062280 Phase 3 Hydrocortisone
5 An Open-label, Randomized, Titration-blinded, Phase III Study of Efficacy, Safety and Tolerability Of Chronocort® Compared With Standard Glucocorticoid REeplacement Therapy in the Treatment of Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia Suspended NCT03532022 Phase 3 Chronocort®;Standard Care
6 Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia Unknown status NCT02096510 Phase 1, Phase 2 Solu-Cortef;Cortef
7 Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Unknown status NCT01771328 Phase 2 Hydrocortisone;Cortisone acetate
8 A Phase 2, Multicenter Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia Completed NCT02804178 Phase 2 ATR-101
9 Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets Completed NCT00000102 Phase 1, Phase 2 Nifedipine
10 Dexamethasone Treatment of Congenital Adrenal Hyperplasia Completed NCT00621985 Phase 2 dexamethasone;Hydrocortisone
11 A Phase 2 Pilot Study to Characterize and Examine the Pharmacokinetics and Disease Bio-marker Response of Chronocort® in Adults With Congenital Adrenal Hyperplasia Completed NCT01735617 Phase 2 Hydrocortisone Modified Release Capsules
12 A Phase 2, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Efficacy of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia (CAH) Completed NCT03257462 Phase 2 SPR001
13 A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients With CAH Completed NCT00519818 Phase 1, Phase 2 Chronocort;Cortef
14 A Pilot Study Assessing the Use of Continuous Subcutaneous Hydrocortisone Infusion in the Treatment of Congenital Adrenal Hyperplasia Completed NCT01859312 Phase 2 Hydrocortisone (Solucortef)
15 A Phase 2, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia Recruiting NCT04045145 Phase 2 NBI-74788
16 A Phase 2, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adult Subjects With Congenital Adrenal Hyperplasia Recruiting NCT03525886 Phase 2 NBI-74788
17 A Multicenter Dose-Titration Open-Label Study of Nevanimibe Hydrochloride for the Treatment of Classic Congenital Adrenal Hyperplasia Recruiting NCT03669549 Phase 2 Nevanimibe hydrochloride
18 A 3-Month Phase 2 Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia Active, not recruiting NCT03687242 Phase 2 SPR001
19 An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children With Congenital Adrenal Hyperplasia Active, not recruiting NCT00001521 Phase 2 Flutamide;Letrozole;Hydrocortisone
20 A Phase 1-2 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children With Classic 21-Hydroxylase Deficiency Not yet recruiting NCT03548246 Phase 2 Abiraterone acetate;Placebo;Hydrocortisone;Fludrocortisone
21 An Open Label, Randomised, Single Dose, 3-period Crossover Study in Healthy Volunteers to: a) Compare the Pharmacokinetics of Chronocort® Formulations Versus Immediate Release Hydrocortisone, and (b) Determine the Dose Proportionality of Chronocort® Formulations Completed NCT03019614 Phase 1 Hydrocortisone;Chronocort
22 A Two-part Open Label, Randomised, Single Dose, Crossover Study in Healthy Volunteers to: (Part A) Compare the Pharmacokinetics of up to 6 Chronocort® Formulations, and (Part B) Determine the Dose Proportionality of a Selected Chronocort® Formulation at Three Dose Levels With an Additional Comparison With the Selected Formulation Dosed on Two Occasions Over a 24 Hour Period Completed NCT03051893 Phase 1 Chronocort
23 An Open-Label, Multiple-Dose, Dose-Finding Study of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency Completed NCT01495910 Phase 1 Abiraterone acetate
24 Interval Bolus Delivery of Subcutaneous Hydrocortisone Via Infusion Pump in Children With Congenital Adrenal Hyperplasia Recruiting NCT03718234 Phase 1 Subcutaneous hydrocortisone;Standard glucocorticoid therapy
25 A Phase 1 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children With Classic 21-Hydroxylase Deficiency Recruiting NCT02574910 Phase 1 Abiraterone acetate
26 A Phase 1, Open-Label, Single-Dose, Sequential Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia Withdrawn NCT02349503 Phase 1 NBI-77860;NBI-77860;NBI-77860
27 Prevalence of Mutations of Glucocorticoid Receptors in Bilateral Adrenal Hyperplasia Unknown status NCT02810496
28 An Adult Height Prediction Model for Congenital Adrenal Hyperplasia From a National Cohort (OPALE Model Study) Unknown status NCT03162159
29 Mutation Analysis of 17α-Hydroxylase Unknown status NCT00172510
30 Long-Term Outcome in Offspring and Mothers of Dexamethasone-Treated Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency Unknown status NCT00617292
31 Potential Modulatory Role of Osteoprotegerin in Bone Metabolism of Patients With 21-Hydroxylase Deficiency Unknown status NCT00694525
32 Evaluation of Adrenocortical Functions by Insulin Tolerance Test and Sodium Depletion in Women With Nonclassical Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Comparison With Healthy Volunteers. Unknown status NCT01862380
33 Clinical Evaluation of the xMAP® NeoPlex4™ Assay for Detection of T4, TSH, 17-OHP and IRT Using the NeoPlex System Completed NCT01488721
34 Health-related Quality of Life, Mental Health and Psychotherapeutic Considerations for Women Diagnosed With a Disorder of Sexual Development: Congenital Adrenal Hyperplasia Completed NCT00559078
35 "Gender Development in Early Adolescence: Prenatal Hormones and Family Socialization" Completed NCT01184651
36 Evaluation of the Adult Height Gain With Growth Hormone Treatment in Children With Congenital Adrenal Hyperplasia (CDAH), Using the OPALE Prediction Model Completed NCT03162172
37 Cross-Sectional Multi-Centre Study of UK Adults With Congenital Adrenal Hyperplasia. Completed NCT00749593
38 Decision Support for Parents Receiving Information About Child's Rare Disease Completed NCT01875640
39 Evaluation of Cardiovascular Risk Profile in Adult Patients With Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency Diagnosed During Childhood Completed NCT01807364
40 Modifier Genes in 21-Hydroxylase Deficiency Completed NCT00542841
41 A Novel Therapeutic Modality for Congenital Adrenal Hyperplasia Completed NCT00529841 Hydrocortisone sodium acetate
42 Catecholamine Reserve and Exercise Tolerance in Subjects With Congenital Adrenal Hyperplasia and Healthy Controls Completed NCT00011791
43 Adrenal Hyperplasia Among Young Patients With Polycystic Ovarian Syndrome Completed NCT01313455
44 Prospective Study Assessing Blood Pressure, Cardiovascular, Endothelial and Other Outcomes poSt-surgical and Medical Treatment in Patients With Primary Aldosteronism Recruiting NCT03174847 Mineralocorticoid Receptor Antagonists
45 Multicentric Evaluation of in Utero Dexamethasone (DEX) on the Cognitive Development of Children at Risk of Congenital Adrenal Hyperplasia Recruiting NCT02795871
46 Dynamic Hormone Diagnostics (Ultradian) Recruiting NCT02934399
47 Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia Recruiting NCT03550261
48 Surgical Evaluation Of Using The Inner Surface Of The Prepuce In Feminizing Genitoplasty In Cases Of Verilized Females With Congenital Adrenal Hyperplasia Recruiting NCT03897504
49 Natural History Study of Patients With Excess Androgen Enrolling by invitation NCT00250159
50 LC-MS / MS Adrenal Steroids Assayed on Dried Blot Spot for the Congenital Adrenal Hyperplasia Neonatal Screening: a Pilot, Multicenter, Prospective Study Not yet recruiting NCT03589144

Search NIH Clinical Center for Adrenogenital Syndrome

Genetic Tests for Adrenogenital Syndrome

Anatomical Context for Adrenogenital Syndrome

MalaCards organs/tissues related to Adrenogenital Syndrome:

41
Adrenal Gland, Cortex, Adrenal Cortex, Testes, Bone, Testis, Ovary

Publications for Adrenogenital Syndrome

Articles related to Adrenogenital Syndrome:

(show top 50) (show all 816)
# Title Authors PMID Year
1
[Chronic suicidality in depression due to untreated adrenogenital syndrome]. 9 38
18679641 2008
2
[From gene to disease: adrenogenital syndrome and the CYP21A2 gene]. 9 38
17557757 2007
3
Clinical and pathological features associated with the testicular tumor of the adrenogenital syndrome. 9 38
17222630 2007
4
Bilateral adrenal myelolipoma associated with adrenogenital syndrome. 9 38
16834664 2006
5
The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis. 9 38
16512598 2005
6
[Seminoma and adrenogenital syndrome]. 9 38
9734185 1998
7
[Problems of delayed diagnosis of an uncomplicated adrenogenital syndrome (AGS) with 21-hydroxylase defect in a 7-year-old boy]. 9 38
9685841 1998
8
Prepubertal acne: a cutaneous marker of androgen excess? 9 38
7829699 1995
9
[Adrenogenital syndrome with 21-hydroxylase deficiency]. 9 38
8413342 1993
10
[Prenatal diagnosis and therapy of adrenogenital syndrome with 21-hydroxylase deficiency]. 9 38
1294431 1992
11
[Prenatal diagnosis and therapy of adrenogenital syndrome with 21-hydroxylase deficiency. Position of the Pediatric Endocrinology Study Group of the German Society of Pediatrics and the Section of Pediatric Endocrinology of the German Society of Endocrinology]. 9 38
1435819 1992
12
[Adrenogenital syndrome. II. Molecular biology]. 9 38
1674383 1991
13
[Experiences with specific screening for early detection of congenital adrenogenital syndrome with 21-hydroxylase defect]. 9 38
2314399 1990
14
Circadian timing of ACTH, beta endorphin, adrenal steroids and testosterone in patients with adrenogenital syndrome (21-hydroxylase deficiency). 9 38
2170988 1990
15
Prenatal diagnosis and treatment of adrenogenital syndrome (steroid 21-hydroxylase deficiency). 9 38
2099900 1990
16
Exome-based search for recurrent disease-causing alleles in Russian population. 38
31028847 2019
17
A rare case of hydrometrocolpos from persistent urogenital sinus in patient affected by adrenogenital syndrome. 38
29502244 2018
18
Giant Cavernous Hemangioma of the Adrenal Gland in an Elderly Patient. 38
29279502 2018
19
Genitoplasty in newborn females with adrenogenital syndrome: Focus on the reconstruction technique and its outcomes. 38
29551555 2018
20
Testicular tumors of adrenogenital syndrome: From physiopathology to therapy. 38
28549629 2017
21
Immunophenotypic differences between neoplastic and non-neoplastic androgen-producing cells containing and lacking Reinke crystals. 38
27696245 2016
22
Idiopathic female pseudohermaphroditism with urethral duplication and female hypospadias. 38
26965407 2016
23
Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature. 38
26660266 2016
24
Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome). 38
26351608 2015
25
[Hemiconvulsion-hemiplegia-epilepsy syndrome in a girl with adrenogenital syndrome]. 38
25534218 2014
26
Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development. 38
25129544 2014
27
Testicular and paratesticular tumors and tumor-like lesions in the first 2 decades. 38
25440720 2014
28
[Endocrine diseases: progress in diagnosis and treatments. Topics: VII. Adrenogenital syndrome and gonadal disorders experienced by internist]. 38
24908988 2014
29
Gender Dysphoria in 46,XX Persons with Adrenogenital Syndrome Raised as Females: An Addendum. 38
25610825 2014
30
[Genetic aspects of fertility disorders]. 38
24337126 2013
31
A unique case of female pseudohermaphroditism with 21-hydroxylase deficiency and small supernumerary marker chromosome 7. 38
23450434 2013
32
50 years ago in the Journal of Pediatrics: female adrenogenital syndrome: early surgical repair. 38
23260311 2013
33
Feminizing genitoplasty: a proven technique. 38
23321870 2013
34
[Pseudotumors of the testis and testicular adnexa]. 38
23057429 2012
35
Role of a disordered steroid metabolome in the elucidation of sterol and steroid biosynthesis. 38
21874273 2012
36
Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia. 38
22173250 2011
37
Histopathological and immunophenotypic features of testicular tumour of the adrenogenital syndrome. 38
21707702 2011
38
Rete testis-associated nodular steroid cell nests: description of putative pluripotential testicular hilus steroid cells. 38
21378545 2011
39
Autopsy and genetic diagnosis of 21-hydroxylase deficiency with bilateral testicular tumors in a case under no medication for over one year. 38
20951518 2011
40
[Keeping in mind adrenogenital syndrome among the causes of prepuberal and puberal gynecomastia]. 38
22111298 2011
41
[Lanthanide fluorescence immunoassay of 17alpha-hydroxyprogesterone in dried blood samples for neonatal screening for adrenogenital syndrome]. 38
21400717 2010
42
Congenital adrenal hyperplasia and Leydig cell tumor of testis. Case report and review of literature. 38
21456481 2010
43
Vaginal replacement in the pediatric age group: a 34-year experience of intestinal vaginoplasty in children and young girls. 38
20920736 2010
44
A 2-year-old boy with a testicular mass. Diagnosis: testicular tumor of adrenogenital syndrome due to 11-beta-hydroxylase deficiency. 38
20704142 2010
45
Cortisone replacement therapy in endocrine disorders - quality of self-care. 38
20210825 2010
46
Microscope-assisted reduction clitoroplasty used to treat two patients with clitoromegaly. 38
20154456 2010
47
[Virilizing congenital adrenogenital syndrome with a de novo I172N mutation: study of a new case]. 38
19819201 2010
48
[Free skin grafts as alternatives in reconstructive plastic surgery of the genitalia]. 38
19300977 2009
49
Vaginoplasty with a pudendal-thigh flap in intersexuals. 38
19122688 2008
50
Clinical implications of a close vicinity of nervus dorsalis penis/clitoridis and os pubis. 38
18331256 2008

Variations for Adrenogenital Syndrome

Expression for Adrenogenital Syndrome

Search GEO for disease gene expression data for Adrenogenital Syndrome.

Pathways for Adrenogenital Syndrome

GO Terms for Adrenogenital Syndrome

Sources for Adrenogenital Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....